Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
Crossref DOI link: https://doi.org/10.1186/s12886-015-0026-y
Published Online: 2015-04-10
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hikichi, Taiichi
License valid from 2015-04-10
Article History
Received: 6 January 2015
Accepted: 28 March 2015
First Online: 10 April 2015